Thousands of Ozempic scripts written for under-18s, data show
Under-18s are receiving scripts for the blockbuster semaglutide drug Ozempic despite it not being TGA-approved for children or adolescents. The Department of Health, Disability and…
Tag: Obesity
A GP guide to managing gout
Gout is one of the most common inflammatory joint diseases and presents a significant burden for many people in Australia. There are several gaps between…
Bariatric surgeons under pressure? Life beyond the $69,000 premiums
Are bariatric surgeons in trouble? Many are facing sky-high premiums fuelled by an apparent rise in patient complaints. And what about the GLP-1s? Will they…
The dismal science returns: How do you make GLP-1 RAs worth taxpayers’ money?
UK Secretary of State for Health and Social Care Wes Streeting. AAP.There are many wondrous things about GLP-1 receptor agonists, not least their capacity to…
Tirzepatide reduces weight more than semaglutide in head-to-head trial of patients without diabetes
Tirzepatide leads to greater weight loss than semaglutide in adults with obesity but without type 2 diabetes, a head-to-head trial suggests. Published in the New…
Semaglutide helps reverse non-alcoholic fatty liver disease, study suggests
Semaglutide may double the resolution rate of non-alcoholic fatty liver disease in patients with stage 2 or 3 fibrosis, a Novo Nordisk-funded study across 37…
Call for doctors prescribing semaglutide to refer patients to dietitians
GPs who prescribe semaglutide should be obliged to also refer those patients on to a dietitian for appropriate counselling, Dietitians Australia says. The organisation’s president…
‘They are devastated’: When your patient discovers stopping semaglutide means the weight returns
Semaglutide is a game changer for patients right up until they stop the treatment, when many face the heartbreak of watching the kilos return. That…
Hundreds of doctors sent warnings for prescribing semaglutide on PBS to patients without diabetes
Health officials have started a mass letter mail-out to doctors they suspect are using the PBS to prescribe subsidised semaglutide to patients without diabetes. Without…
TGA approves Wegovy for reducing MACE risk
The TGA has approved Wegovy to reduce the risk of major adverse events in patients with cardiovascular disease who are overweight or obese. The once-weekly…
